Home › NDC Lookup › RxCUI directory › RxCUI 2645244

Abiraterone acetate 500 MG / niraparib 50 MG Oral Tablet — RxCUI 2645244

RxNorm drug concept · Semantic clinical drug
RxCUI 2645244 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2645244
Official nameAbiraterone acetate 500 MG / niraparib 50 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asabiraterone acetate 500 MG / niraparib 50 MG (equivalent to 76.9 MG niraparib tosylate) Oral Tablet
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Abiraterone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Abiraterone blocks an enzyme that prostate cancer cells use to make the male hormones they need to grow — not just in the testes, but also in the adrenal glands and in the tumor it...
  • What exactly does abiraterone do, and why do I need to take it with prednisone?
  • Yes, this is really important and it depends on which product you have. Most abiraterone tablets — including Zytiga, Abirtega, and the generics — must be taken on a completely empt...
  • Does it matter when I eat? My neighbor takes a different abiraterone and he eats with it.
📖 Read our full Abiraterone guide →

🕸️ Concept Web — How Abiraterone acetate 500 MG / niraparib 50 MG Ora... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Abiraterone acetate 500 MG / niraparib 50 MG Oral Tablet RxCUI 2645244

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Abiraterone 1100072
    • Niraparib 1918231
    • Abiraterone / niraparib 2645240
    • Abiraterone acetate 1100071
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Akeega 2645245
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Abiraterone / niraparib Oral Tablet 2645243
    • Abiraterone acetate / niraparib Oral Tablet 2647579
    • Abiraterone / niraparib Oral Product 2645241
    • Abiraterone / niraparib Pill 2645242
    • Abiraterone acetate / niraparib Oral Product 2661253
    • Abiraterone acetate / niraparib Pill 2663256
    • Abiraterone / niraparib Oral Tablet [Akeega] 2645249
    • Abiraterone acetate / niraparib Oral Tablet [Akeega] 2657665
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 17 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Abiraterone acetate 500 MG SCDC · 1918041
  • Niraparib 50 MG SCDC · 2645239
  • Abiraterone / niraparib Oral Tablet SCDF · 2645243
  • Abiraterone acetate / niraparib Oral Tablet SCDFP · 2647579
  • Abiraterone / niraparib Oral Product SCDG · 2645241
  • Abiraterone / niraparib Pill SCDG · 2645242
  • Abiraterone acetate / niraparib Oral Product SCDGP · 2661253
  • Abiraterone acetate / niraparib Pill SCDGP · 2663256

Brand-Name Concepts

  • Abiraterone acetate 500 MG / niraparib 50 MG Oral Tablet [Akeega] SBD · 2645250
  • Abiraterone acetate 500 MG / niraparib 50 MG [Akeega] SBDC · 2645246
  • Abiraterone / niraparib Oral Tablet [Akeega] SBDF · 2645249
  • Abiraterone acetate / niraparib Oral Tablet [Akeega] SBDFP · 2657665
  • Akeega Oral Product SBDG · 2645247
  • Akeega Pill SBDG · 2645248
  • Akeega BN · 2645245

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2645244 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
57894-0050-60 1 BOTTLE in 1 CARTON (57894-050-60) / 60 TABLET, FILM COATE... AKEEGA Janssen Biotech, Inc. 2023-08-11
57894-0100-60 1 BOTTLE in 1 CARTON (57894-100-60) / 60 TABLET, FILM COATE... AKEEGA Janssen Biotech, Inc. 2023-08-11
Observed labelers: Janssen Biotech, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.